🇺🇸 FDA
Pipeline program

N-Acetyl cysteine

2020-0412

Phase 2 small_molecule active

Quick answer

N-Acetyl cysteine for Neurofibromatosis 1 is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Neurofibromatosis 1
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials